Technology and Expenditure Growth in Health Care
-
Upload
gwendolyn-fuller -
Category
Documents
-
view
24 -
download
0
description
Transcript of Technology and Expenditure Growth in Health Care
![Page 1: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/1.jpg)
Technology and Expenditure Growth in Health Care
Amitabh Chandra HARVARD UNIVERSITY
![Page 2: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/2.jpg)
United StatesSweden
DenmarkGermany
IrelandNetherlands
AustriaSwitzerland
NorwayFranceCanada
JapanIcelandFinland
BelgiumAustralia
New ZealandGreece
UKPortugal
Spain
0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 16.0
Health Care Share of GDP for OECD Countries in 1980
US is not an outlier
![Page 3: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/3.jpg)
United StatesSweden
DenmarkGermany
IrelandNetherlands
AustriaSwitzerland
NorwayFranceCanada
JapanIcelandFinland
BelgiumAustralia
New ZealandGreece
UKPortugal
Spain
0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 16.0
Health Care Share of GDP for OECD Countries in 2010
![Page 4: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/4.jpg)
United StatesSweden
DenmarkGermany
IrelandNetherlands
AustriaSwitzerland
NorwayFrance
CanadaJapan
IcelandFinland
BelgiumAustralia
New ZealandGreece
UKPortugal
Spain
0.0 1.0 2.0 3.0 4.0 5.0 6.0 7.0
Health Care Share of GDP for OECD Countries Increase from 1980-2010
Outlier?
![Page 5: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/5.jpg)
Houston...we have a problem...
This particular insurance company has made promises to its policy holders that have a current value $40 trillion… in excess of the revenues that it expects to receive…..
Think of the United States government as a gigantic insurance company with a sideline business in national defense…
This particular insurance company has made promises to its policy holders that have a current value $20 trillion… in excess of the revenues that it expects to receive…..
It is an accident waiting to happen.
Peter FisherUndersecretary of the TreasuryNovember 2002
Congressional Budget Office (CBO)September 2010
![Page 6: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/6.jpg)
Incomplete Understanding of Tradeoffs
![Page 7: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/7.jpg)
Questions and Puzzles• What is the association between
technology growth and rising health care expenditures?
• Why have U.S. health care expenditures grown so rapidly, relative to other countries, but without consistently better outcomes?
![Page 8: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/8.jpg)
• Medical technologies differ in their average productivity
• Some technologies have high average productivity, others are lesser average productivity
• US reimbursement system leads to the adoption of lower productivity technologies
• Reimbursement system encourages more innovation in lower (average) productivity technologies
![Page 9: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/9.jpg)
xx*
The Productivity of Medical Treatments
Cost per patient
x*
Marginal Benefit from Treatment
Treatment (X)
![Page 10: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/10.jpg)
xx*
Cost per patient
The Productivity of Medical Treatments
x* x*x*
Marginal Benefit from Treatment
Treatment (X)
![Page 11: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/11.jpg)
xx*
Cost per patient
The Productivity of Medical Treatments Marginal
Benefit from Treatment
x*x*
High Average Productivity
(just about everyone benefits)
Lower average productivity
Treatment (X)
![Page 12: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/12.jpg)
A Typology of Health Care Treatments
1. Highly cost-effective innovations
2. Potentially Cost-Effective, with Heterogeneity in Benefits
3. Technologies with Uncertain Effectiveness
![Page 13: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/13.jpg)
Benefits (area under the curve) and Costs of Category I
Innovation
![Page 14: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/14.jpg)
Source: Swartz, MN, NEJM Oct 28, 2004
![Page 15: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/15.jpg)
![Page 16: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/16.jpg)
A Typology of Health Care Treatments
1. Highly cost-effective innovations
2. Potentially Cost-Effective, with Heterogeneity in Benefits
3. Technologies with Uncertain Effectiveness
![Page 17: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/17.jpg)
PCI (Angioplasty and Stents)
![Page 18: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/18.jpg)
![Page 19: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/19.jpg)
![Page 20: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/20.jpg)
![Page 21: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/21.jpg)
![Page 22: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/22.jpg)
Patients Receiving Procedure
0
Benefit from Procedure
100 percent
Rapid Angioplasty within 2 hours of
AMI
“Late” Angioplasty
within 2 days of AMI Angioplasty for Stable
Coronary Disease
OVERUSE?
![Page 23: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/23.jpg)
Primary PCI
Stable Angina
# Patients
Cost per PCI
Stents are Highly Cost-Effective for some
Marginal Benefit from Treatment
![Page 24: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/24.jpg)
# Patients
Cost per PCI
Total Cost
X’
But less so for the marginal patient
Marginal Benefit from Treatment
![Page 25: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/25.jpg)
# Patients
Cost per PCI
Total Cost
X Z
Different beliefs about benefits
Small Differences in Beliefs have large cost-implications
Marginal Benefit from Treatment
![Page 26: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/26.jpg)
Three Categories of Health Care Treatments
1. Highly cost-effective innovations
2. Potentially Cost-Effective Treatments with Heterogeneity in Benefits
3. Technologies with Uncertain Effectiveness
![Page 27: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/27.jpg)
![Page 28: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/28.jpg)
![Page 29: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/29.jpg)
Fixed Cost: $150 millionBenefit: Unknown
PROTON BEAM THERAPY
Medicare reimburses $6000 per treatment
![Page 30: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/30.jpg)
![Page 31: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/31.jpg)
Proton Beam Accelerator Facilities Operating, Planned, or Under Construction
![Page 32: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/32.jpg)
Accounting for Improved Cardiovascular Health 1980-
2000% Mortality
Decline Type of Medical/Surgical Treatment or Risk Factor Change
61% Decline: smoking, hypertension, cholesterol, physical inactivity
-17% Rise: body-mass index (BMI) and diabetes
44% Subtotal: Deaths prevented: health risk factors
22% Aspirin, heparin, warfarin, anti-hypertensives, β-blockers, diuretics
13% Statins, ACE Inhibitors, IIb/IIIa antagonists, thrombolytics
12%Angioplasty/stents, bypass surgery (CABG), cardio-pulmonary resuscitation, cardiac rehabilitation
47% Subtotal: Deaths prevented: health care
10% Unexplained
100% Total deaths prevented (341,745 total)
Source: Ford, et al., NEJM 2007.
![Page 33: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/33.jpg)
How to Think About Health Care Costs
Improved Health
Increased Costs
Aspirin, heparin, warfarin, anti-hypertensives, β-blockers, diuretics
Statins, ACE Inhibitors, IIb/IIIa antagonists, thrombolytics
Angioplasty/stents, bypass surgery (CABG), cardio-pulmonary resuscitation, cardiac rehabilitation
![Page 34: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/34.jpg)
Highest Performance
Lowest Performance
Source: Chandra, Skinner and Staiger (2010). IOM.
Category II and III Technologies
Cate
gory
I
Tech
nolo
gie
s
![Page 35: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/35.jpg)
Summing Up• The U.S. is different -- more
“Category III” spending and not necessarily more “Category I” implies faster growth relative to GDP.
• Big potential for cost-saving institutional reform -- could swamp importance of cost-saving technologies
• Rising taxes – ultimate brake on health care spending?
Rest of
World
US
0
350
700
1050
1400
1750
20072009
Barbash and Glied, NEJM 2010
![Page 36: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/36.jpg)
Summing Up• The U.S. is different -- more
“Category III” spending and not necessarily more “Category I” implies faster growth relative to GDP.
• Big potential for cost-saving institutional reform -- management is a Category I technology
• Rising taxes – ultimate brake on health care spending?
![Page 37: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/37.jpg)
Summing Up• The U.S. is different -- more
“Category III” spending and not necessarily more “Category I” implies faster growth relative to GDP.
• Big potential for cost-saving institutional reform -- management is a Category I technology
• Rising taxes – ultimate brake on health care spending?
![Page 38: Technology and Expenditure Growth in Health Care](https://reader036.fdocuments.us/reader036/viewer/2022062517/568133f7550346895d9ae9cb/html5/thumbnails/38.jpg)